Crossmark

European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification

Crossref DOI link: https://doi.org/10.1007/s00405-025-09609-0

Published Online: 2025-08-04

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wierzbicka, Malgorzata https://orcid.org/0000-0003-0006-6352
Baidun, Agatha https://orcid.org/0009-0002-2073-0273
Bertolin, Andy

Lionello, Marco https://orcid.org/0000-0002-2454-9618
Succo, Giovanni https://orcid.org/0000-0003-0375-6623
Verbist, Berit https://orcid.org/0000-0002-1010-2583
Farina, Davide https://orcid.org/0000-0003-4075-0001
Hendriksma, Martine https://orcid.org/0000-0001-5254-8842
Remacle, Marc https://orcid.org/0000-0003-2525-3154
Simo, Ricard https://orcid.org/0000-0002-5410-1566
Sjogren, Elisabeth https://orcid.org/0000-0001-7990-8510
Piazza, Cesare https://orcid.org/0000-0002-2391-9357
License Information

Text and Data Mining valid from 2025-08-04

Version of Record valid from 2025-08-04
More Information

Article History

Received: 5 April 2025

Accepted: 16 July 2025

First Online: 4 August 2025

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Not applicable.

: The authors declare that they have no conflict of interest.